Overall, the findings revealed that DR5/TRAIL-mediated apoptosis pathway had played important roles in the injury of ARS mice, and DR5 probably be a potential target for ARS therapeutics. The gene discussed is TNFRSF10B; the disease is Axenfeld-Rieger syndrome.